Advertisement
News
Subscribe to MDT Magazine News

BioDrain Medical, Inc. Retains CFSG1 as Its U.S. Investor Relations Firm

March 15, 2011 3:33 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, March 15, 2011 /- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR ), producer of the FDA cleared Streamway™ System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 ("CFSG1") as its U.S. Investor Relations...

TOPICS:

OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical Inc. (OTC Bulletin Board: ONCSD ), a developer of innovative and proprietary medical approaches to treat solid tumor cancers with unmet medical needs, announced today that it has signed an agreement with Inovio Pharmaceuticals, Inc. (NYSE Amex:...

TOPICS:

Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

BLUE BELL, Pa., March 15, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has signed an agreement with OncoSec Medical Inc. (OTC Bulletin Board:...

TOPICS:
Advertisement

OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 15, 2011 /- OncoSec Medical, Inc. (OTC Bulletin Board: ONCSD ) announced today that Mr. Punit Dhillon, President and CEO, will present a company overview on Wednesday, March 16 at 2:00 pm PT at the ROTH 23rd Annual Growth Stock Conference being held at the Ritz-Carlton,...

TOPICS:

ARMSRx and 84 Lumber Hammer Down Rx Costs...Again

March 15, 2011 12:34 am | by Bio-Medicine.Org | Comments

EIGHTY FOUR, Pa., March 15, 2011 /- ARMSRx Pharmacy Benefit Consulting, the nation's leading Pharmacy Benefit consulting firm, has consistently provided successful recommendations for their clients. On February 16th, ARMSRx presented results to one of their premier clients, 84 Lumber....

TOPICS:

AMSC to significantly expand wind business through proposed acquisition of power technologies company "The switch?

March 14, 2011 10:38 pm | by I-Micronews | Comments

American Superconductor Corporation (NASDAQ: AMSC), a global power technologies company, today announced that it has signed a definitive agreement to acquire The Switch Engineering Oy, a power technologies company headquartered in Finland.

Nursing home boom in China has little government involvement

March 14, 2011 9:39 pm | by EurekAlert | Comments

(Brown University) A new study of the growth and operation of nursing homes in Chinese cities finds that the industry, while still small, is surging to meet the country's overwhelming shift toward an older population. The almost entirely private-sector growth has far outpaced...

TOPICS:

U.S. FDA Approves Bayer's Gadavistâ„¢ (Gadobutrol) Injection for MRI of the Central Nervous System

March 14, 2011 9:36 pm | by Bio-Medicine.Org | Comments

WAYNE, N.J., March 14, 2011 /- Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist™ (gadobutrol) Injection, a macrocyclic gadolinium-based contrast agent (GBCA), for intravenous use in diagnostic magnetic resonance...

TOPICS:
Advertisement

Reportlinker Adds Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017

March 14, 2011 1:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017...

TOPICS:

Reportlinker Adds Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

March 14, 2011 1:35 pm | by Bio-Medicine.Org | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017...

TOPICS:

Pradaxa Gains Preferred Formulary Status with Key Pharmacy Benefit Managers

March 14, 2011 1:33 pm | by Bio-Medicine.Org | Comments

RIDGEFIELD, Conn., March 14, 2011 /- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), today announced that Pradaxa® (dabigatran etexilate mesylate) capsules has received preferred Tier 2 formulary status with CVS Caremark (Commercial Preferred Drug List) and Medco (Commercial...

TOPICS:

Lextron to buy Animal Health Intl in $111M deal

March 14, 2011 12:45 pm | by The Associated Press | Comments

Shares of Animal Health International Inc. climbed Monday after the company said it agreed to be acquired by privately held Lextron Inc. for $111 million in cash.Lextron will buy all outstanding shares of Animal Health for $4.25 each, a premium of about 11 percent compared to the stock's...

Tumor suppressor blocks viral growth in natural HIV controllers

March 14, 2011 11:39 am | by EurekAlert | Comments

(Massachusetts General Hospital) Elevated levels of p21, a protein best known as a cancer fighter, may be involved in the ability of a few individuals to control HIV infection with their immune system alone. In the April edition of the Journal of Clinical Investigation, researchers...

TOPICS:

Repligen gets positive results on improved pancreatic MRI

March 14, 2011 11:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Repligen Corp. today reported positive results from a Phase 3 study of RG1068, a synthetic human secretin designed to improve magnetic resonance imaging of the pancreas.

TOPICS:

Reportlinker Adds Insulin Lispro - Comprehensive Patent Search

March 14, 2011 11:37 am | by Bio-Medicine.Org | Comments

NEW YORK, March 14, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Insulin Lispro - Comprehensive patent search http://www.reportlinker.com/p0447411/Insulin-Lispro----Comprehensive-patent-search.html Eliminate unnecessary risk with the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading